Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7999843 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| SCHEMBL8459195 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| SCHEMBL19032670 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| SCHEMBL19032668 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| SCHEMBL7999840 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| SCHEMBL359431 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| Hydrochloric Acid SCHEMBL7073709 | 0.98 | ALDH1A1 (0.51) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| SCHEMBL7490711 | 0.98 | ALDH1A1 (0.51) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| Hydrochloric Acid SCHEMBL7073702 | 0.98 | ALDH1A1 (0.51) | ALDH1A1CNR1HPGDTRPV1CNR2 | |
| Hydrochloric Acid SCHEMBL8629416 | 0.98 | ALDH1A1 (0.51) | ALDH1A1CNR1HPGDTRPV1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114479781-B | Low-condensation-point emulsifier and preparation method thereof | 中国石油化工股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-112875748-B | Preparation method of sea urchin-shaped titanium dioxide multistage microsphere negative electrode material | 陕西科技大学 | 2023-03-10 | — | — | CN | claimed |
| CN-112875748-A | Preparation method of sea urchin-shaped titanium dioxide multistage microsphere negative electrode material | 陕西科技大学 | 2021-06-01 | — | — | CN | claimed |
| CN-112159147-A | Environment-friendly concrete antifreezing pumping aid and preparation method thereof | 潍坊兴乐建材有限公司 | 2021-01-01 | — | — | CN | claimed |
| CN-106479702-A | A kind of toilet cleaner and preparation method thereof | 长兴净安环保科技有限公司 | 2017-03-08 | — | — | CN | claimed |
| CN-106479781-A | A kind of efficient sterilizing decontamination toilet cleaner and preparation method thereof | 长兴净安环保科技有限公司 | 2017-03-08 | — | — | CN | claimed |
| EP-3103435-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH OR PREVENTING HAIR LOSS | Neopharm Co., Ltd. (KR) | 2016-12-14 | — | — | EP | claimed |
| US-20160354293-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH OR PREVENTING HAIR LOSS | NEOPHARM CO., LTD. (KR) | 2016-12-08 | — | — | US | claimed |
| EP-2985276-A1 | FORMULATIONS BASED ON NANOEMULSIONS AND THE USE THEREOF FOR TREATING OBESITY | Fundación Pública Andaluza Para La Investigación de Malaga en Biomedicina y Salud (FIMABIS) (ES) | 2016-02-17 | — | — | EP | claimed |
| US-20150265551-A1 | OPHTHALMIC, INTRA-ARTICULAR OR INTRAVESICAL PREPARATIONS CONTAINING N-ACYL-ETHANOLAMINES | Epitech Group S.r.I. (IT) | 2015-09-24 | — | — | US | claimed |
| WO-2008006007-A2 | DEFECTIVE CYSTIC FIBROSIS TRANSDUCTION REGULATOR (CFTR) CAUSES INCREASED SPHINGOLIPID SYNTHESIS | COLUMBIA UNIVERSITY (US) | 2008-01-10 | — | — | WO | claimed |
| EP-1250119-B1 | REDUCTION OF HAIR GROWTH | GILLETTE CO (US) | 2007-10-03 | — | — | EP | claimed |
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | claimed |
| US-20060194260-A1 | Screening assays for cannabinoid-ligand-type modulators of gpr55 | ASTRAZENECA AB (SE) | 2006-08-31 | — | — | US | claimed |
| EP-1595146-A1 | SCREENING ASSAYS FOR CANNABINOID-LIGAND-TYPE MODULATORS OF GPR55 | AstraZeneca AB (SE) | 2005-11-16 | — | — | EP | claimed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| WO-2004074844-A1 | SCREENING ASSAYS FOR CANNABINOID-LIGAND-TYPE MODULATORS OF GPR55 | ASTRAZENECA AB (SE) | 2004-09-02 | — | — | WO | claimed |
| US-6190894-B1 | APPLYING INHIBITORS OF BIOSYNTHESIS OR DEGRADATION, DEGRADATION ENZYMES, AND/OR INHIBITORS AND ACTIVATORS OF METABOLIC ENZYMES; FOR TOPICAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-02-20 | — | — | US | claimed |
| CN-87101878-A | The fuel composition that is used for porous fuel injection system | — | 1987-10-21 | — | — | CN | claimed |
| US-4529528-A | Reacting an alkoxylated amine and a phosphite | MOBIL OIL CORPORATION (US) | 1985-07-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150265551-A1 | OPHTHALMIC, INTRA-ARTICULAR OR INTRAVESICAL PREPARATIONS CONTAINING N-ACYL-ETHANOLAMINES | UACA, AADAC, PHOSPHO1 | ALDH1A1 916/4885CNR1 316/4885HPGD 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.